Abstract
IntroductionSuper-response (SR), defined as a cessation of oral corticosteroid (OCS) therapy and elimination of exacerbation, is a key treatment goal among patients with severe asthma (SA) on monoclonal antibody (mAb)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
